Incidence of dengue fever and its clinical profile during an outbreak in a rural area in Tamil Nadu by Somasundaram, Deepak et al.
Vol 6 | Issue 5 | May 2019 Indian J Child Health 209
Original Article
Incidence of dengue fever and its clinical profile during an outbreak in a rural 
area in Tamil Nadu
Deepak Somasundaram1, Somasundaram Marimuthu2, Kavitha Thiruselvam3, Shankar Radhakrishnan4
From 1Junior Consultant, 2Consultant, 3Medical Officer, Department of Pediatrics, M.S Children’s Hospital, Gobichettipalayam, 4Statistician and 
Epidemiologist, Department of Preventive Medicine, Vinayaka Mission’s Kirupananda Variyar Medical College and Hospital, Salem, Tamil Nadu, India
Correspondence to: Dr. Kavitha Thiruselvam, Department of Pediatrics, M.S Children’s Hospital, Gobichettipalayam, Erode, 
Tamil Nadu - 638452. Email- dr.tkay@gmail.com
Received - 14 March 2019 Initial Review - 25 March 2019 Accepted - 18 April 2019
Dengue fever is a mosquito-borne disease caused by flavivirus with four distinct virus serotypes DEN-1, DEN- 2, DEN-3, and DEN-4 [1]. Approximately 400 
million dengue cases occur worldwide every year in which, only 
25% of the cases are detected by the public health surveillance 
system while the remaining 75% cases go unnoticed [2]. In 
Southeast Asian countries, dengue is the major cause of pediatric 
morbidity and mortality among which, India reports the maximum 
number of cases. The annual incidence of dengue in India ranges 
from 8 to 33 million cases per year [3].
The most common vector involved in dengue was Aedes 
albopictus which was found to be more abundant in the areas 
surveyed, followed by Aedes aegypti. Among the four serotypes, 
serotype 2 was reported with more severe inflammatory response 
leading to severe dengue infection. According to the WHO 
reports, the case fatality rate for dengue was 5%, but studies had 
shown that the mortality ranged from <1% in classical dengue to 
44% in untreated dengue hemorrhagic fever [4]. An increased risk 
of dengue virus infection in children older than 5 years has been 
documented, though there are case reports of neonatal dengue 
virus transmission [5,6].
Clinically, non-severe dengue is characterized by fever, 
headache, retro-ocular pain, myalgia and arthralgia, nausea and 
vomiting, lymphangitis, and exanthema. Some patients were 
presented with complications such as intense abdominal pain, 
persistent vomiting, tachypnea, petechiae, and other hemorrhagic 
manifestations, as well as neurological signs and a mild altered 
mental status, which are considered as warning signs [7,8]. 
Besides the signs and symptoms previously described, patients 
with severe dengue were reported with signs of plasma leakage 
or severe bleeding and severe end-organ damage [9,10]. In the 
pediatric population with dengue, high fevers, abdominal pain, 
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age older than 6 years, hepatomegaly and thrombocytopenia 
(<50,000/mm3) have been described as strong predictors of the 
severity of the disease [11]. Measuring platelet counts may be 
unavailable in primary level health-care units. Dengue shock 
syndrome is a potentially lethal complication of severe dengue 
virus infection, especially in children; therefore, maintaining 
hemodynamic stability is the usual recommendation for inpatient 
management of dengue [12,13].
For a disease that is complex in its manifestations, management 
is relatively simple, inexpensive and very effective in saving lives 
if correct and timely interventions are administered. The key 
for a better prognosis in dengue is to understand and be alert to 
the clinical problems that arise during the different phases of the 
disease and about the rationality in case management [14]. Dengue 
mortality can be reduced by implementing early case detection and 
referral systems for patients. It also includes managing severe cases 
with appropriate treatment; reorienting health services to cope with 
dengue outbreaks, and training health-care personnel of all levels 
of the health-care system [15]. Although prior studies had been 
conducted on the clinical profile of dengue, only a few studies had 
been reported from a rural part of Tamil Nadu, India. Hence, the 
present study was undertaken in studying the clinical picture and the 
management outcome of dengue fever and to assess the predictive 
variables for the severity of dengue and their clinical outcomes.
METHODOLOGY
A prospective longitudinal study was conducted at a pediatric 
hospital in a rural area of Tamil Nadu, for a period of 6 months 
from June 2017 to November 2017. The study center is a 
secondary level care National Accreditation Board for Hospitals 
accredited pediatric hospital which was established 30 years back 
in Gobichettipalayam (Tamil Nadu). The study was started after 
getting the ethical clearance certificate. All patients in the age 
group of <16 years with complaints of fever and were willing to 
get admitted to the hospital, were included for the study. All those 
cases who were admitted with fever had initial screening done 
for enteric fever, malaria, and urinary tract infection along with 
blood counts. A total of 325 patients were included in the study 
based on the study period and the inclusion criteria. The informed 
consent was obtained from the parent or guardian accompanying 
the patient. For all the fever cases basic blood investigations 
which include hemoglobin, total count, and platelet count were 
performed along with peripheral smear study for malaria, dengue 
card test, and liver function test. Both card tests and ELISA were 
performed between the 3rd and 7th days of their illness.
Further, dengue positive patients were grouped into non-
severe and severe dengue fever based on the operational definition 
formulated by the WHO. Patients with symptoms of headache, 
fever, retro-ocular pain, arthralgia, myalgia, exanthema, 
intense abdominal pain, persistent vomiting, tachypnea, and 
neurological disturbances or altered mental status were classified 
as non-severe dengue. Severe dengue is characterized by evident 
bleeding, with anemia, hematocrit changes, and hypovolemic 
shock. Patients were also observed for plasma leakage signs such 
as shock syndrome or tachycardia and cutaneous manifestations 
of peripheral vasoconstriction; fluid accumulation with acute 
respiratory distress syndrome, pleural effusion or ascites, and 
increased hematocrit (>20%). Patients with signs related to severe 
end-organ compromise such as liver damage (jaundice, acute liver 
failure, and encephalopathy) or gastrointestinal (persistent vomit, 
progressive, or intense abdominal pain), altered mental status and 
profound neurologic disturbances (lethargy, restlessness, coma, 
seizures or encephalitis), cardiac compromise (cardiomyopathy), 
and kidney injury (acute kidney injury) or other organs if occurred 
were recorded. In addition to, the patient’s clinical profile all data 
related to the patients socio-demographic characteristics such as 
age, gender, residential address, date of hospital admission, date 
of first contact with health services due to the probable diagnosis 
of dengue virus infection, travelling to other locations in the 
previous 15 days, and the laboratory results, were noted.
All the data were entered and analyzed using SPSS version 21; 
mean and the standard deviation was derived for all the parametric 
variables. Chi-square test was used for analyzing the statistical 
inference considering p<0.05 as statistically significant.
RESULTS
The minimum age of the patient reported to our hospital was 
3 months and the maximum age was 15 years. Males were found to 
be slightly more in number than the females with a male:female ratio 
of 1.3:1. In our study, we found that the majority of the patients with 
complaints of fever were in the age group of 12 and 15 years and 
the overall mean age was 10.3 years. Out of 325 patients who were 
presented with fever, 232 patients were ELISA dengue IgM antibody 
positive, with an incidence of 71.3%. This high incidence of dengue 
was due to the study carried out during the outbreak of dengue in the 
state (Tamil Nadu). Majority of the patients with dengue fever was 
found to be in the age group of more than 12 years (Table 1).
The dengue fever was classified as non-severe dengue and 
severe dengue based on the WHO classification. In our study 
subjects among the dengue fever case, we found that 294 (83.6%) 
of the patients had non-severe dengue and the remaining 
38 (16.3%) had severe dengue. Almost all the patients presented 
with dengue had fever along with other common symptoms such 
as headache, coryza, abdominal pain, and retro-orbital pain. 
Conjunctiva congestion, vomiting, oliguria, and diarrhea were 
found to be more common among severe dengue patients than 
that of the non-severe dengue (p<0.05). In our study, seizures 
were also reported in two patients with severe dengue fever.
Among the various clinical signs elicited in dengue cases, we 
found hepatomegaly, lymphadenopathy, and epigastric tenderness 
were the most common signs seen in most of the patients with 
dengue fever, whereas particular signs such as palmar erythema, 
splenomegaly, and bleeding manifestations were more common 
in severe dengue patients than that of non-severe dengue and 
this difference was found to be statistically significant (Table 2). 
Ascites was seen in four patients with <1 year of age, and pleural 
effusion (11 patients) was found to be common in older children 
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and two children had encephalopathy and all these were seen in 
patients with severe dengue fever.
Laboratory investigations revealed that hemoglobin and 
platelet count was found to be significantly lower among the 
patients with severe dengue than that of non-severe dengue 
(p<0.05), whereas the total count did not show much variation 
between the two groups. Similarly in the liver function test the 
total protein and albumin did not show significant difference 
between the two groups, whereas the serum glutamic-oxaloacetic 
transaminase (SGOT) and serum glutamic pyruvic transaminase 
(SGPT) levels showed a gross increase in patients with severe 
dengue than that of the non-severe dengue and the difference was 
found to be statistically significant (p<0.05) (Table 3).
Most of the cases in non-severe dengue were managed with 
symptomatic management with antipyretics such as paracetamol 
either given intramuscularly or orally. More than 50% of the 
patients in non-severe dengue group had received an antibiotic like 
doxycycline, while very few patients a crystalloid (13.4%) in this 
group compared to patients with severe dengue (63.1%). Similarly, 
none of the patients in the non-severe dengue group received blood 
transfusion whereas, 21% of patients with severe dengue received 
a blood transfusion and this difference was found to be statistically 
significant (Table 4). No mortality was reported in our study 
subjects in both the severe and non-severe dengue patients.
DISCUSSION
The current study had shown the incidence of dengue, during 
an epidemic, was 71%. Among them, 84% had the non-severe 
type of dengue and the remaining 16% had severe dengue based 
on the WHO classification for dengue fever. A similar type of 
incidence was also reported in a study conducted by Jain [16]. 
In our study, children in the age group between 10 and 15 years 
were found to be more commonly infected with dengue followed 
by 6–10 years, and male to female ratio was 1.3:1 and similar 
pattern was seen in the retrospective analysis of the 2006 North 
Indian dengue outbreak [16]. A study done by Sahana and Sujatha 
had also quoted that boys are slightly more affected than girls, 
which might be due to outdoor activities of male children, where 
chances of getting bitten with mosquitoes are more [17].
In the current study, fever was the major presenting complaint 
in almost all patients. Headache, coryza, retro-orbital pain, and 
abdominal pain are the other most common symptoms reported in 
the present study which is on par with the previous studies [18,19]. 
Vomiting, oliguria, and diarrhea were found to be more common 
in severe dengue than that of non-severe dengue, andsimilar 
findings had been observed in a study conducted by Ahmed 
et al. [20]. Central nervous system (CNS) involvement was seen 
in two of the patients who were presented with drowsiness, altered 
sensorium, and later developed convulsions. Involvement of the 
CNS in dengue fever is recognized more frequently; dengue 
Table 1: Age‑ and sex‑wise distribution of dengue positive cases 










<3 15 (11.6) 5 (4.8) 20 (8.6) 0.638
3–6 12 (9.3) 6 (5.8) 18 (7.7)
6–9 17 (13.1) 20 (19.4) 37 (15.9)
9–12 32 (24.8) 30 (29.1) 62 (26.7)
12–15 53 (41) 42 (40.7) 95 (40.9)
Table 2: Distribution of the various clinical signs and symptoms 








Frequency (%) Frequency (%)
Fever 194 (100) 38 (100) 1.000
Conjuctiva congestion 63 (32.4) 34 (89.4) <0.05
Coryza 162 (83.5) 30 (78.9) 0.712
Headache 155 (79.8) 26 (68.4) 0.681
Abdominal pain 138 (71.1) 26 (68.4) 0.818
Retro-orbital pain 146 (75.2) 24 (63.1) 0.549
Vomiting 54 (27.8) 22 (57.8) <0.05
Oliguria 23 (11.8) 31 (81.5) <0.05
Diarrhea 13 (6.7) 18 (47.3) <0.05
Seizures 0 (0) 2 (5.2) 0.071
Palmar erythema 31 (15.9) 28 (73.6) <0.05
Hepatomegaly 172 (88.6) 32 (84.2) 0.785
Splenomegaly 98 (50.5) 27 (71) <0.05
Lymphadenopathy 166 (85.5) 30 (78.9) 0.889
Epigastric tenderness 174 (89.6) 33 (86.8) 0.815
Bleeding manifestations 0 (0) 38 (100) <0.05
Ascites 0 (0) 4 (10.5) <0.05
Pleural effusion 0 (0) 11 (28.9) <0.05
Table 3: Various laboratory investigations performed among 








Total blood count 8181±1898.6 7518±2018.5 0.818
Hemoglobin 11.6±2.8 9.8±3.2 <0.05
Platelet count 108,650±20,564.8 45,890±9,760.7 <0.05
Total protein 7.2±0.89 6.3±1.28 0.716
SGOT 78±18.8 127±31.6 <0.05
SGPT 49.3±16.4 74.6±21.4 <0.05
Albumin 4.3±1.18 3.8±1.71 0.616
SGOT: Serum glutamic‑oxaloacetic transaminase, SGPT: Serum glutamic pyruvic 
transaminase, SD: Standard deviation
Table 4: Various types of management among patients with dengue 
fever







Symptomatic/antipyretics 67 (34.5) 0 <0.05
Doxycycline tablets 101 (52) 6 (15.7) <0.05
Crystalloids 26 (13.4) 24 (63.1) <0.05
Blood products 0 8 (21) <0.05
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encephalopathy should be considered as a possibility in any child 
presenting with neurological symptoms in endemic areas.
Overall hepatomegaly was seen in 88% in the present study 
which was similar to other previous studies where they found 
hepatomegaly was more common in severe dengue cases than non-
severe dengue [19,21]. However, in our study, we did not find any 
significant difference in the occurrence of hepatomegaly between 
severe and non-severe dengue. Ascites (10.5%) and pleural effusion 
(28.5%) were significantly high in severe dengue as compared to 
non-severe dengue fever which is statistically significant (p<0.001). 
The presence of these signs helps in predicting the severity of the 
disease as noted in other studies also. In the current study, we found 
low hemoglobin levels and low platelet levels are more common 
in severe dengue cases than that of non-severe dengue, whereas 
the total count did not show any significant difference between 
the two groups and a similar report was also quoted in the studies 
done by Agarwal et al. and Srinivasa et al. [21,22]. Among the liver 
function test, we did not find any difference in the total proteins 
and albumin levels between the two groups whereas the SGOT and 
SGPT levels were significantly increased among severe dengue 
cases compared to non-severe cases, similar results were observed 
by Kalayanarooj et al. Mayosites involvements leads increase of 
aspartate transaminase and alanine aminotransferase [23].
In the present study, 76% of dengue affected children required 
crystalloids among which 63% were in severe dengue and 13% were 
non-severe dengue and a similar type of finding was also observed 
in the study done by Srinivasa et al. [22]. Colloids were not used in 
any patients as by adopting the revised the WHO classification. The 
WHO, in their recent guidelines on the management of dengue, 
has described stepwise approach to the management of dengue, 
where only isotonic solutions have been advised, followed by serial 
monitoring of clinical status, fluid balance, and hematocrit. For 
21% of patients with severe dengue, blood products were used and 
it is almost similar to the study done by Sahana and Sujatha [17]. 
Judicious use of fluid was advised to maintain effective circulation 
during the leak period. Previous studies had shown that the 
mortality rate for dengue varies from 0 to 12%, similarly, in our 
study, no death due to dengue had occurred.
CONCLUSION
Dengue fever is becoming a major public health problem in 
India and the incidence of severe dengue is constantly increasing 
particularly in children in the age group between 5 and 15 years. 
All levels of health-care personnel must be made aware of the 
clinical signs and symptoms of all dengue types. Early recognition, 
precise assessment and appropriate treatment with the help of the 
WHO revised classification and management guidelines would 
reduce the mortality due to dengue fever.
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